Dr. Dayan Goodenowe, PHD

Dr. Dayan Goodenowe, PhD, is a neuroscientist, biochemist, and pioneer in the field of preventive medicine. As founder and CEO of Prodrome Sciences, he has dedicated his career to uncovering the biochemical foundations of chronic diseases, including Alzheimer’s, Parkinson’s, and multiple sclerosis. His discovery of “biochemical prodromes” has redefined how we predict and address neurodegenerative conditions. Dr. Goodenowe is also the author of Breaking Alzheimer’s and founder of the Dr. Goodenowe Restorative Health Center, where he applies advanced biochemical restoration in clinical care. He is a dynamic speaker known for translating complex science into actionable insights.